BROOKLYN IMMUNOTHERAPEUTICS (BTX)
US1140821000 - Common Stock
ChartMill assigns a Buy % Consensus number of 80% to BTX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 3.06. This target is 1391.96% above the current price.
BTX was analyzed by 5 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about BTX.
In the previous month the buy percentage consensus was at a similar level.
Only 5 analysts analyzed BTX. So this is just the average opinion of a couple of analysts.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-10-12 | Maxim Group | Downgrade | Buy -> Hold |
| 2021-12-29 | Cantor Fitzgerald | Initiate | Overweight |
| 2021-10-06 | Maxim Group | Initiate | Buy |